+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global qPCR Instruments Market Size, Share & Trends Analysis Report by Test Type (7500, QuantStudio Dx, QuantStudio 5, ViiA 7 Dx, One Step/One Step Plus, LightCycler 2.0, Cobas 4800, CFX96, SmartCycler), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 109 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5450264
The global qPCR instruments market size is expected to reach USD 1.64 billion by 2030. It is expected to expand at a CAGR of 7.0% from 2023 to 2030. The market is driven by the introduction of novel advanced products and an increase in demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is being driven by the spike in the incidence of SARS-CoV-2 infections globally. The rise in the incidence is expected to add to the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular assays is expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic tests to yield quick and effective test results. For instance, the Mic qPCR system by Biomolecular Systems weighs only 2 kilograms, making the device highly portable and easy to handle.

Newly launched products such as QuantStudio 5 Dx Real-Time PCR System provide consumers with improved workflows and high-volume testing to provide faster results. Cost-effectiveness and software that are simplified give it additional advantages. Furthermore, the approval of the instrument in over 50 countries can help strengthen the market growth. The instrument is also equipped with measures for research companion diagnostics, giving it a competitive edge.

The market has a high threat of external substitutes owing to the presence of digital PCR instruments that are highly advanced and more accurate. The strong threat of internal substitution can be attributed to the presence of numerous products available in the market. However, the higher price of these instruments is anticipated to reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are preferred more in developed economies as they can help reduce false-positive rates. The research on developing efficient qPCR instruments can reduce the threat of substitution of devices and improve market growth.

Over recent years, PCR has witnessed technological advancements in terms of sensitivity, accuracy, efficiency, and cost-effectiveness. Key players are introducing novel technologies to maintain a competitive edge.

qPCR Instruments Market Report Highlights

  • The GeneXpert segment accounted for the largest revenue share of 21.67% in 2022. This is attributed to its increased adoption rate during the SARS-CoV-2 pandemic to detect infections.
  • The Rotor-Gene Q 5Plex HRM System segment is expected to grow at the fastest CAGR of 8.8% during the forecast period owing to the factors such as Rotor-Gene Q 5Plex HRM System can deliver results in as little as 90 minutes, which is faster than many other qPCR instruments.
  • North America dominated the global qPCR instruments market and accounted for the largest revenue share of 42.73% in 2022. The growth of this region is attributed to the growing regulatory support and increasing launches of novel products.
  • Asia-Pacific is expected to grow at the fastest CAGR of 8.9% over the forecast period. The major untapped opportunities in the form of unmet medical needs, increasing initiatives for scientific research, and positive economic growth are primary growth drivers of this market.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Test Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. qPCR Instruments Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. qPCR Instruments Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. qPCR Instruments: Test Type Estimates & Trend Analysis
4.1. qPCR Instruments Market: Key Takeaways
4.2. qPCR Instruments Market: Movement & Market Share Analysis, 2022 & 2030
4.3. 7500
4.3.1. 7500 market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. QuantStudio Dx
4.4.1. Quant Studio Dx market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. QuantStudio 5
4.5.1. Quant Studio 5 market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. ViiA 7 Dx
4.6.1. ViiA 7 Dx market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. One Step/One Step Plus
4.7.1. One Step/One Step Plus market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. LightCycler 2.0
4.8.1. Light Cycler 2.0 market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Cobas 4800
4.9.1. Cobas 4800 market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. CFX96
4.10.1. CFX96 market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. SmartCycler
4.11.1. Smart Cycler market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. GeneXpert
4.12.1. GeneXpert market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Rotor-Gene Q 5Plex HRM System
4.13.1. Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Rotor-Gene Q
4.14.1. Rotor-Gene Q market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. BIOFIRE FILMARRAY System
4.15.1. BIOFIRE FILMARRAY Systems market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. BMS Mic System
4.16.1. BMS Mic System market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. qPCR Instruments Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. qPCR Instruments Market by Region: Key Takeaway
5.3. North America
5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Key Country Dynamics
5.3.2.2. Regulatory Framework/Reimbursement Structure
5.3.2.3. Competitive Scenario
5.3.2.4. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Key Country Dynamics
5.3.3.2. Regulatory Framework/Reimbursement Structure
5.3.3.3. Competitive Scenario
5.3.3.4. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.6. Denmark
5.4.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5. Asia-Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Thermo Fisher Scientific, Inc.
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. F. Hoffmann-La Roche Ltd.
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Bio-Rad Laboratories, Inc.
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Danaher
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. QIAGEN
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Agilent Technologies, Inc.
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Abbott
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. BIOMÉRIEUX
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Quantabio
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Azure Biosystems Inc.
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Bio Molecular Systems
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 3 North America qpcr instruments market, by region, 2018-2030 (USD Million)
Table 4 U.S. qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 5 Canada qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 6 Europe qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 7 Europe qpcr instruments market, by region, 2018-2030 (USD Million)
Table 8 Germany qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 9 UK qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 10 France qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 11 Italy qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 12 Spain qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 13 Denmark qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 14 Sweden qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 15 Norway qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 16 Asia-Pacific qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 17 Asia-Pacific qpcr instruments market, by region, 2018-2030 (USD Million)
Table 18 Japan qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 19 China qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 20 India qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 21 Australia qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 22 Thailand qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 23 South Korea qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 24 Latin America qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 25 Latin America qpcr instruments market, by region, 2018-2030 (USD Million)
Table 26 Brazil qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 27 Mexico qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 28 Argentina qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 29 Middle East and Africa qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 30 Middle East and Africa qpcr instruments market, by region, 2018-2030 (USD Million)
Table 31 South Africa qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 32 Saudi Arabia qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 33 UAE qpcr instruments market, by test type, 2018-2030 (USD Million)
Table 34 Kuwait qpcr instruments market, by test type, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 QFD modeling for market share assessment
Figure 6 Market formulation & validation
Figure 7 qPCR instruments: Market outlook
Figure 8 qPCR instruments: Competitive insights
Figure 9 Parent market outlook
Figure 10 Related/ancillary market outlook
Figure 11 Penetration and growth prospect mapping
Figure 12 qPCR instruments market driver impact
Figure 13 qPCR instruments market restraint impact
Figure 14 qPCR instruments market strategic initiatives analysis
Figure 15 qPCR instruments market: Test Type movement analysis
Figure 16 qPCR instruments market: Test Type outlook and key takeaways
Figure 17 7500 market estimates and forecasts, 2018-2030 (USD Million)
Figure 18 QuantStudio Dx market estimates and forecasts, 2018-2030 (USD Million)
Figure 19 QuantStudio 5 market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 ViiA 7 Dx market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 One Step/One Step Plus market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 LightCycler 2.0 market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Cobas 4800 market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 CFX96 market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 SmartCycler market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 GeneXpert market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Rotor-Gene Q 5Plex HRM System market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Rotor-Gene Q market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 BIOFIRE FILMARRAY SYSTEMS market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 BMS Mic System market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Global qPCR instruments market: Regional movement analysis
Figure 32 Global qPCR instruments market: Regional outlook and key takeaways
Figure 33 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 UK market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Asia-Pacific market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Middle East and Africa. market estimates and forecasts, 2018-2030
Figure 57 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • QIAGEN
  • Agilent Technologies, Inc.
  • Abbott
  • BIOMÉRIEUX
  • Quantabio
  • Azure Biosystems Inc.
  • Bio Molecular Systems

Methodology

Loading
LOADING...